Attending the The MedTech Conference Conference? Visit the MLSC team and our partners at MassMEDIC at Booth 818, to learn why Massachusetts is the number one life sciences ecosystem. Massachusetts is the home of revolutions and age defining breakthroughs. Your Why is Here. Learn more: https://lnkd.in/eiKvNkcq
Massachusetts Life Sciences Center
Government Administration
Waltham, Massachusetts 10,493 followers
The Heart of the Hub
About us
The Massachusetts Life Sciences Center (MLSC) is an economic development and investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world. Through public-private funding initiatives, the MLSC supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. Since its creation in 2007, the MLSC has strategically deployed over $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.
- Website
-
http://www.masslifesciences.com
External link for Massachusetts Life Sciences Center
- Industry
- Government Administration
- Company size
- 11-50 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Government Agency
- Founded
- 2007
- Specialties
- life sciences, grants, biotech, economic development, medical device, tax incentives, investment, workforce pipeline, biomanufacturing, internships, capital investment, innovation economy, and big data
Locations
-
Primary
1075 Main St
100
Waltham, Massachusetts 02451, US
Employees at Massachusetts Life Sciences Center
-
David Hendren
Executive Leader | Early & Growth Stage Entrepreneur | Board Director | Strategic Advisor | Venture and Private Equity Investor
-
Stuart Abelson
-
Pam Randhawa
CEO | BOD: Massbio, MLSC, Hercules Capital | Biotechnology | Diagnostics | Digital Health
-
Kristina Cates
Outreach, Education, and Curriculum Design
Updates
-
A great day for our ecosystem celebrating the unveiling of Vertex Pharmaceuticals' Jeffrey Leiden Center for Cell and Genetic Therapies. During her remarks, Governor Maura Healey announced $21.4 million in tax incentive awards to 19 life sciences companies. The awards, provided through the MLSC’s Tax Incentive Program, are expected to create 1,155 new life sciences industry jobs in Massachusetts. Read more: https://lnkd.in/e_vAmzFt
-
+5
-
The MLSC is hosting virtual info sessions for the opportunity to learn more about the Center and its recently launched programs. These programs include Research Infrastructure, Bits to Bytes, Novel Therapeutics Delivery, the Women’s Health Initiative, and our new Health Equity program. Learn more: https://lnkd.in/e_u-mPWU
-
A special day for our ecosystem and for celebrating breakthroughs as the 2024 Nobel Prize in Physiology or Medicine was awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation. The MLSC is proud of its continued partnership with UMass Chan Medical School, Massachusetts General Hospital, Harvard Medical School, and institutions across Massachusetts to accelerate the impact of cutting-edge technologies and supporting groundbreaking ideas in RNA-based medicines and other breakthroughs that can transform lives on a global scale. Read more on the Nobel Prize: https://lnkd.in/eFU7DuZf Read more via UMass Chan: https://lnkd.in/ekTRbvUC Read more via MGH: https://lnkd.in/eqx9fXjw Read more from Harvard Medical School: https://lnkd.in/eGa5t9M4
-
Today, the Healey-Driscoll administration announced that Dr. Kirk Taylor will serve as the Massachusetts Life Science Center’s (MLSC) new President and CEO. Taylor is a trained neurologist who brings more than 25 years of industry experience, including medical affairs and clinical development strategy, entrepreneurial vision, and strategic leadership, to the role. The MLSC Board of Directors voted to confirm Taylor’s role today, and he will begin on October 8. Read more: https://lnkd.in/e3hi9sfk
-
Our partners at MassBio unveiled their five-year strategic plan, Vision 2030, a framework outlining a series of ambitious goals to further Massachusetts’ status as the world’s premier life sciences hub. The plan lays out a path to add up to $1 billion to the state’s GDP by the start of 2030, and to create hundreds more biopharma and life sciences jobs, among other initiatives. Read more: https://ow.ly/WqeA50TBPZo
-
In September 2023, Massachusetts secured the federal Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub. Since the launch of the Hub, numerous Massachusetts-based companies and institutions have secured upwards of more than $300 million from ARPA-H, including more than $70 million just in the past two weeks. The Hub’s base of operations being in Massachusetts is no accident. The state’s selection to host the Investor Catalyst Hub demonstrates the federal government’s recognition of Massachusetts as a leading model for health care delivery and life sciences innovation. 🔗 https://lnkd.in/g7asURUB
-
New application rounds of MLSC programming for Research Infrastructure, Bits to Bytes, Novel Therapeutics Delivery, and our Women’s Health Initiative, are now underway. The MLSC is adding an additional layer of equity to these returning programs during the application process, asking applicants to not only consider gender diversity, but other overlooked factors such as race, geography, and other social determinants of health. The Center is also launching a new Health Equity program to provide smaller grants in areas around health equity. Read more: https://lnkd.in/eFQ4KmnG
-
Join us Oct. 28-29 at the 14th Annual PODD: Partnership Opportunities in Drug Delivery conference. #PODD2024 combines cutting-edge business and scientific content in the field of drug delivery along with a wide range of networking opportunities. 700+ Pharma, biotech and drug delivery industry attendees gather annually at PODD to assess delivery needs, latest trends and to learn about a wide range of innovative drug delivery technologies. Learn more: https://ow.ly/y13g50T6xYA